Affinity Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Affinity Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$17.2M	Buy	+139,859	New	+$17.4M	2.33%	23

Other funds holding PJP

HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return

Beacon Harbor Wealth Advisors Virginia Beach, Virginia $526M AUM 34.64% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Trek Financial Scottsdale, Arizona $2.16B AUM 42.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Vicus Capital State College, Pennsylvania $1.58B AUM 16.34% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Joseph Group Capital Management Columbus, Ohio $562M AUM 15.17% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Affinity Wealth Management's PJP Position: Q3 2026 in Review

Affinity Wealth Management opened a new position in Invesco Pharmaceuticals ETF (PJP) in Q3 2026: 139,859 shares worth $17.2M. The stake represents 2.33% of the portfolio and ranks #23 among its holdings.

92 funds tracked by Wall St. Rank hold PJP as of Q3 2026.

Affinity Wealth Management held 139,859 shares of Invesco Pharmaceuticals ETF worth $17.2M as of Q3 2026.
Invesco Pharmaceuticals ETF was a new Affinity Wealth Management position in Q3 2026.
Invesco Pharmaceuticals ETF made up 2.33% of Affinity Wealth Management's portfolio in Q3 2026, its #23 holding.
92 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2026.

Based on Affinity Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.